Abstract:An important aspect of PTSD care is treatment tolerability, which impacts patient adherence and the overall success of treatment. Dropout rates from recommended psychological therapies for PTSD are high, particularly for trauma-focused interventions (6). Gahnfelt et al.'s evaluation of an 8-day intensive treatment for severe PTSD suggests that while intensive treatments can be beneficial, they also present challenges. Their study reported a low rate of treatment dropout, reduced PTSD symptom burden, and no adverse effects, indicating that intensive treatment is a viable option, though further is needed to confirm its effectiveness.Addressing PTSD comprehensively involves understanding and treating both its psychological and physiological aspects. Individuals with PTSD often experience heightened arousal symptoms, such as increased heart rate, hypervigilance, and exaggerated startle responses (1). In their paper, Leech et al. explored the relationship between PTSD and interoceptive awareness -the ability to perceive internal bodily sensations. Chronic stress associated with PTSD can dysregulate the body's stress response system, leading to long-term neurobiological and hormonal changes (7), which may heighten the risk of physical health conditions. Enhancing interoceptive awareness could improve emotional resilience and reduce PTSD symptom severity. Within this collection, Jiang and Yang investigated the association between PTSD and cancer risk, finding limited evidence suggesting a link between PTSD ovarian cancer. This underlines the need for further research into the biological mechanisms underlying such associations.In summary, the collection of papers within this Research Topic highlights the need for a comprehensive understanding of PTSD and trauma-informed clinical practice. The findings collectively advocate for a more nuanced and compassionate approach to PTSD care, emphasizing the integration of psychological, social, and biological perspectives in designing tailored interventions. This integration allows clinicians to develop personalized treatment plans that are more effective and holistic. Such an approach facilitates early identification, appropriate intervention, and continuous support, leading to improved symptom management, enhanced quality of life, and reduced risk of comorbid conditions. By increasing awareness and understanding of PTSD across healthcare settings, educational institutions, and communities, we can destigmatize mental health issues and promote early detection and intervention. Moreover, continued investment in research is crucial for advancing our knowledge of PTSD mechanisms and treatment outcomes, paving the way for innovative therapeutic approaches and evidence-based practices. Moving forward, collaborative research and interdisciplinary partnerships are essential for translating knowledge into actionable strategies that promote resilience, recovery, and well-being. By fostering a culture of empathy, inclusivity, and scientific rigor, we can create a future where PTSD is addressed with understanding, compassion, and effective treatment options.

An insight into crosstalk among multiple signalling pathways contributing to the pathophysiology of PTSD and depressive disorders

Neuromodulation Strategies in Post-Traumatic Stress Disorder: From Preclinical Models to Clinical Applications

Emphasizing the Crosstalk Between Inflammatory and Neural Signaling in Post-traumatic Stress Disorder (PTSD)

Molecular and cell signaling targets for PTSD pathophysiology and pharmacotherapy

Neurophysiology and Psychopathology Underlying PTSD and Recent Insights into the PTSD Therapies—A Comprehensive Review

Post-traumatic stress disorder: the role of the amygdala and potential therapeutic interventions – a review

A Neuroanatomic and Pathophysiologic Framework for Novel Pharmacological Approaches to the Treatment of Post-traumatic Stress Disorder

Mechanisms of developing post-traumatic stress disorder: new targets for drug development and other potential interventions

New approaches to combining pharmacotherapy and psychotherapy for posttraumatic stress disorder

Dysregulation of inflammation, neurobiology, and cognitive function in PTSD: an integrative review

Editorial: Break the mental health stigma: PTSD

The neural circuits and molecular mechanisms underlying fear dysregulation in posttraumatic stress disorder

Genes and hormones of the hypothalamic-pituitary-adrenal axis in post-traumatic stress disorder. What is their role in symptom expression and treatment response?

Post-traumatic Stress Disorder: A Narrative Review of Pharmacological and Psychotherapeutic Interventions

Common and Divergent Neuroimaging Features in Major Depression, Posttraumatic Stress Disorder and Their Comorbidity

New recognition of the heart-brain axis and its implication in the pathogenesis and treatment of PTSD

Prevention and treatment of PTSD: the current evidence base

Brain circuit dysfunction in post-traumatic stress disorder: from mouse to man

Recognition of the neurobiological insults imposed by complex trauma and the implications for psychotherapeutic interventions

Newer insights into the role of miRNA a tiny genetic tool in psychiatric disorders: focus on post-traumatic stress disorder

PTSD biomarkers: Neuroendocrine signaling to epigenetic variants